Skip to main content
Erschienen in: Obesity Surgery 2/2018

Open Access 31.07.2017 | Original Contributions

Risk Factors for Prolonged Length of Hospital Stay and Readmissions After Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass

verfasst von: Piotr Major, Michał Wysocki, Grzegorz Torbicz, Natalia Gajewska, Alicja Dudek, Piotr Małczak, Michał Pędziwiatr, Magdalena Pisarska, Dorota Radkowiak, Andrzej Budzyński

Erschienen in: Obesity Surgery | Ausgabe 2/2018

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LRYGB) are most commonly performed bariatric procedures. Laparoscopic approach and enhanced recovery after surgery (ERAS) protocols managed to decrease length of hospital and morbidity. However, there are patients in whom, despite adherence to the protocol, the length of stay (LOS) remains longer than targeted. This study aimed to assess potential risk factors for prolonged LOS and readmissions.

Methods

The study was a prospective observation with a post-hoc analysis of bariatric patients in a tertiary referral university teaching hospital. Inclusion criteria were undergoing laparoscopic bariatric surgery. Exclusion criteria were occurrence of perioperative complications, prior bariatric procedures, and lack of necessary data. The primary endpoints were the evaluations of risk factors for prolonged LOS and readmissions.

Results

Median LOS was 3 (2–4) days. LOS > 3 days occurred in 145 (29.47%) patients, 79 after LSG (25.82%) and 66 after LRYGB (35.48%; p = 0.008). Factors significantly prolonging LOS were low oral fluid intake, high intravenous volume of fluids administered on POD0, and every additional 50 km distance from habitual residence to bariatric center. The risk of hospital readmission rises with occurrence of intraoperative adverse events and low oral fluid intake on the day of surgery on.

Conclusions

Risk factors for prolonged LOS are low oral fluid intake, high intravenous volume of fluids administered on POD0, and every additional 50 km distance from habitual residence. Risk factors for hospital readmission are intraoperative adverse events and low oral fluid intake on the day of surgery.

Introduction

Nowadays, laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LRYGB) are becoming first-line treatment for morbid obesity in Poland and worldwide, with widely accepted low risk for postoperative morbidity and low mortality [15]. In addition, treating patients in accordance with enhanced recovery after surgery (ERAS) protocols has reduced the length of stay (LOS) and decreased morbidity [6, 7]. Despite that, some patients with successful adherence to the protocol and uneventful peri- and post-operative period fail to meet discharge criteria and remain a longer period of time than targeted LOS. Shorter LOS may be associated with an increased rate of readmissions, and in some patients it results in readmission for variety of reasons [810].
The relationship between perioperative complications occurrence and prolonged LOS seems to be obvious, but the interesting question is what is affecting LOS in uncomplicated patients. Therefore, we analyzed risk factors for prolonged hospitalization and hospital readmission in order to predict patients without complications who might require longer hospital observation.

Aim

Study aim was to identify risk factors for prolonged length of hospital stay and unplanned readmission after laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass among patients with uncomplicated postoperative course.

Methods

The study was a prospective observation with a post-hoc analysis of patients who underwent bariatric surgery in a tertiary referral university teaching hospital. The indication for surgical treatment was taken from the IFSO-EC and EASO guidelines: body mass index (BMI) ≥ 35 kg/m2 with comorbidities or BMI of ≥ 40 kg/m2 [11, 12]. The inclusion criteria were written informed consent upon hospital admission acknowledging that the outcomes of perioperative treatment and follow-up may be analyzed retrospectively and used for research, age of 18 to 65 years, and eligibility for LSG or LRYGB. Exclusion criteria were occurrence of perioperative complications, prior bariatric procedures, and lack of necessary data. Study was designed according to STROBE Statement [13].
Patients were treated in accordance with the principles of multimodal ERAS pathway, including preoperative, intraoperative, and postoperative interventions [2, 6, 1416]. Preoperative interventions included extensive perioperative counseling, shortened fluid fasts, preoperative high protein and carbohydrate drink, and optimized operating scheduling times. Intraoperatively, the optimized bariatric anesthetic protocol was introduced with the use of multimodal analgesia. There was no routine use of nasogastric tubes and intraabdominal drains. Postoperative interventions included early mobilization, analgesia without opioids, administration of IPP-antagonist, early enteral feeding, and discharge planning. Anti-thrombotic prophylaxis was administered up to 14 postoperative days with the use of Enoxaparine. Detailed information on protocol used in our clinic is presented below:
1.
Preoperative counseling and patient’s education
 
2.
Pre-operative carbohydrate loading (400 ml of Nutricia preOp® 2 h prior surgery)
 
3.
Antithrombotic prophylaxis (Clexane® 40 mg sc. starting in the evening prior surgery)
 
4.
Antibiotic prophylaxis (preoperative Ceftriaxone 2 g iv 30–60 min. prior surgery)
 
5.
Laparoscopic surgery
 
6.
Balanced intravenous fluid therapy (< 2500 ml intravenous fluids during the day of surgery, less than 150 mmol sodium). Indication for administration of i.v. fluids after surgery: vomiting, insufficient oral fluid intake (less than 500 ml before 7:00 pm, 7 h after surgery), insufficient diuresis (less than 500 ml of urine before 7:00 pm, 7 h after surgery). The target is to not use intravenous fluids in POD1. Fluids were given only if we observed absence of sufficient functional recovery: vomiting, insufficient oral fluid intake (less than 500 ml until 4:00 pm), insufficient diuresis, or biochemical symptoms of rhabdomyolysis
 
7.
No nasogastric tubes postoperatively
 
8.
No drains left routinely
 
9.
TAP block and bariatric anesthesia protocol
 
10.
Avoiding opioids, multimodal analgesia (oral when possible—Paracetamol 4 × 1 g, Ibuprofen 2 × 200 mg, Metamizole 2 × 500 mg, or Ketoprofen 2 × 100 mg); routine use of ondansetron, metoclopramide, and deksametazon at the end of the surgery
 
11.
Postoperative oxygenation therapy (4–6 l/min)
 
12.
Early oral feeding (oral nutritional supplement 4 h postoperatively—Nutrcia Nutridrink® or Nestlé Impact®, light hospital diet, and oral nutritional supplements on the first postoperative day, full hospital diet in the second postoperative day)
 
13.
Early mobilization on the day of surgery (sitting on the bed 2 h after surgery, breathing exercises with physiotherapist, walking to the toilette, and walking along the corridor (at least 150 m) accompanied by an ERAS nurse or a family member. Full mobilization on the first postoperative day (getting out of bed, going to the toilette, walking along the corridor without support of the nurse, at least 4–6 h out of bed)
 
On admission, every patient was informed about the target length of stay of 3 days. Discharge criteria:
  • Oral diet tolerance (solid food consumption, drinking at least 1500 ml of fluids)
  • No need for i.v. drugs or fluids
  • Balanced diuresis
  • Pain of low magnitude, manageable with oral pain killers
  • No fever
  • Properly healing surgical wounds
  • Physical activity at a level similar to pre-surgery time
  • No complications requiring in-hospital observation
  • Other’s people help available in the first days after surgery
  • Possibility to return to hospital when suspecting complication development (means to contact, transportation from home)
Patients were scheduled for postoperative appointment 2 weeks after discharge, next 1 and 6 months after discharge. Surgical techniques for LSG and LRYGB were standardized in all cases to reduce study bias.
The primary endpoints were the evaluations of risk factors for prolonged length of stay and of risk factors for readmissions in the postoperative period in the group of patients without complications.
LOS was defined as the length of inpatient episode of care, calculated from the day of admission to the day of discharge, and based on the number of nights spent in hospital. The discharge occurred regardless of the day of the week. Patients were dichotomized into group of patients whose hospital stay was shorter or equal to the target LOS (≤3 days) and group of patients with prolonged LOS, defined as total length of stay in bariatric care unit longer than 3 days. Readmission was defined as hospitalization after discharge from bariatric care unit related to bariatric treatment within 30-days postoperative period.
Comparison of baseline patients data was done using Student’s t test or Mann-Whitney’s test for quantitative variables, while χ2 with or without Yates’ correction were used for qualitative variables. Univariate and multivariate logistic regression models were built to assess influence of patient- and treatment-related parameters on odds ratios (OR) with 95% confidence intervals (95% CI) for prolonged hospital stay and hospital readmissions. P value < 0.05 was considered statistically significant. Data were analyzed using Statistica version 12.0 PL (StatSoft Inc., Tulsa, Oklahoma, USA). Quantitative data are expressed as mean ± standard deviation or medians with interquartile range.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Jagiellonian University.

Material

From April 2009 to July 2016, 543 patients were treated for morbid obesity. Then, 492 patients met inclusion criteria and were submitted to laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass [310 females, 182 males, median age 42 (34–51) years] (Table 1). Flow chart of patients in the study is shown in Fig. 1.
Table 1
Patients and groups baseline characteristics
Parameter
All patients
 
492 (100%)
Females, n (%)
310 (63%)
Males, n (%)
182 (37%)
Median age, years (IQR)
42 (34–51)
Median maximal preoperative BMI, kg/m2 (IQR)
46.56 (42.89–51.50)
Median BMI on a day of operation, kg/m2 (IQR)
45.09 (41.31–49.74)
∆BMI (IQR)
0.98 (0–2.42)
ASA class, n (%)
1
11 (2.30%)
2
333 (69.52%)
3
135 (28.18%)
Cardiovascular diseases, n (%)
87 (17.68%)
Hypertension, n (%)
335 (68.23%)
Prediabetes, n (%)
22 (4.47%)
Diabetes mellitus, n (%)
168 (34.29%)
Obstructive sleep apnea, n (%)
35 (7.11%)
Non-alcoholic fatty liver disease, n (%)
306 (62.45%)
Dyslipidemia, n (%)
278 (56.85%)
IQR interquartile range, ASA class American Society of Anesthesiologists physical status classification system

Results

Median length of hospital stay (LOS) was 3 (2–4) days. LOS > 3 days occurred in 145 (29.47%) patients, 79 after LSG (25.82%), and 66 after LRYGB (35.48%; p = 0.008). Factors possibly prolonging length of hospital stay were analyzed in univariate logistic regression models. Maximal preoperative BMI > 51.50 kg/m2, LRYGB, operative time, intraoperative adverse events, high intraoperative volume of administered fluids, low postoperative oral fluid intake and diuresis, need for Furosemide forced diuresis, high postoperative intravenous fluid volume, postoperative tachycardia, occurrence of postoperative fever, postoperative nausea and vomiting, requirement for additional pain medication, every 50 km distance between place of residence and bariatric center were significantly related to the risk of prolonged LOS (LOS > 3 days vs. ≤ 3 days) (Table 2). Therefore, those possibly relevant factors were analyzed in multivariate logistic regression model (Table 3). Factors significantly prolonging LOS were low oral fluid intake, high intravenous volume of fluids administered on POD0, and every additional 50 km distance from habitual residence to bariatric center.
Table 2
Univariate logistic regression models for odds ratio of prolonged LOS (> 3 vs. ≤ 3 days)
Factors
OR
95% CI
P
Patient-related
Sex (M = 0, F = 1)
0.91
0.61–1.35
0.629
Age (with every 1 year)
0.99
0.97–1.01
0.374
Age (> 51 vs. ≤ 51 years)
1.07
0.68–1.70
0.761
Maximal preoperative BMI (1 kg/m2)
1.03
0.99–1.06
0.056
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2)
1.55
1.01–2.39
0.047
BMI on the day of operation (1 kg/m2)
1.02
0.99–1.06
0.119
BMI on the day of operation (> 49.74 vs. ≤ 49.74 kg/m2)
1.41
0.91–2.18
0.124
Co-morbidities
ASA class (with every point)
1.36
0.91–2.04
0.133
Cardio-vascular diseases (yes = 1, no = 0)
1.60
0.98–2.60
0.058
Arterial hypertension (yes = 1, no = 0)
1.21
0.79–1.84
0.388
Prediabetes (yes = 1, no = 0)
1.39
0.57–3.39
0.470
Diabetes mellitus (yes = 1, no = 0)
1.25
0.84–1.88
0.271
Obstructive sleep apnea (yes = 1, no = 0)
1.27
0.61–2.63
0.518
Non-alcoholic fatty liver disease (yes = 1, no = 0)
0.94
0.63–1.40
0.752
Dyslipidemia (yes = 1, no = 0)
1.36
0.91–2.02
0.131
Malnutrition (yes = 1, no = 0)
1.42
0.92–2.19
0.113
Treatment-related
Type of procedure (LRYGB vs. LSG)
1.58
1.06–2.35
0.023
Operative time (with every 1 min)
1.01
1.00–1.01
<0.001
Operative time (> 150 vs. ≤ 150 min)
2.05
1.29–3.24
0.002
Intraoperative adverse effects (yes = 1, no = 0)
3.99
1.51–10.53
0.005
Intraoperative fluid volume administered (500 ml)
1.52
1.24–1.87
<0.001
Postoperative period
Oral fluid intake on POD0 (100 ml)
0.80
0.74–0.85
<0.001
Oral fluid intake on POD1 (100 ml)
0.88
0.85–0.91
<0.001
Oral fluid intake on POD2 (100 ml)
0.94
0.91–0.97
<0.001
Oral fluid intake on POD3 (100 ml)
1.08
0.88–1.32
0.464
Diuresis on POD0 (1000 ml)
1.85
1.44–2.40
<0.001
Diuresis on POD1 (1000 ml)
1.20
0.91–1.57
0.190
Diuresis on POD2 (1000 ml)
1.29
0.94–1.75
0.111
Diuresis on POD3 (1000 ml)
28.95
0.08–10,888
0.261
Furosemide forced diuresis (yes = 1, no = 0)
2.52
1.58–4.02
<0.001
Intravenous fluid intake on POD0 (yes = 1, no = 0)
1.04
0.68–1.59
0.851
Intravenous fluid volume on POD0 (500 ml)
1.55
1.04–2.31
0.032
Intravenous fluid intake on POD1 (yes = 1, no = 0)
4.89
2.87–8.35
<0.001
Intravenous fluid volume on POD1 (500 ml)
1.57
1.34–1.83
<0.001
Intravenous fluid intake on POD2 (yes = 1, no = 0)
8.44
5.06–14.06
<0.001
 
Intravenous fluid volume on POD2 (500 ml)
1.56
1.18–2.06
0.002
Heart rate on POD0 (with every 1/min)
1.01
0.99–1.03
0.452
Tachycardia on POD0 (yes = 1, no = 0)
9.82
1.08–89.19
0.042
Heart rate on POD1 (with every 1/min)
0.99
0.97–1.01
0.420
Tachycardia on POD1 (yes = 1, no = 0)
1.50
0.48–4.69
0.482
Heart rate on POD2 (with every 1/min)
1.01
0.99–1.03
0.591
Tachycardia on POD2 (yes = 1, no = 0)
2.04
0.50–8.32
0.319
Heart rate on POD3 (with every 1/min)
1.00
0.97–1.03
0.940
Tachycardia on POD3 (yes = 1, no = 0)
1.22
0.11–13.84
0.874
CPK (> 1000 vs. < 1000 U/L)
1.55
0.87–2.74
0.135
Postoperative fever (yes = 1, no = 0)
2.50
1.50–4.15
<0.001
Postoperative nausea and vomiting (yes = 1, no = 0)
2.57
1.19–5.57
0.016
Additional pain medication required (yes = 1, no = 0)
1.95
1.30–2.94
0.001
Distance between the hospital and place of residence (50 km)
1.18
1.08–1.28
<0.001
Italic entries reached significance of p < 0.05 as stated in methodology
ASA class American Society of Anesthesiologists physical status classification system, POD0 postoperative day 0, POD1 postoperative day 1, POD2 postoperative day 2, POD3 postoperative day 3, POD4 postoperative day 4, CPK creatine phosphokinase
Table 3
Multivariate logistic regression models for odds ratio of prolonged LOS (> 3 vs. ≤ 3 days)
 
OR
95% CI
P
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2)
1.11
0.39–3.13
0.849
Type of procedure (LRYGB vs. LSG)
0.74
0.25–2.21
0.590
Operative time (> 150 vs. ≤ 150 min)
1.11
0.36–3.38
0.859
Intraoperative adverse effects (yes = 1, no = 0)
1.88
0.37–9.49
0.439
Intraoperative fluid volume administered (500 ml)
0.75
0.45–1.24
0.255
Oral fluid intake on POD0 (100 ml)
0.77
0.67–0.88
<0.001
Intravenous fluid volume on POD0 (500 ml)
1.71
1.03–2.82
0.036
Diuresis on POD0 (1000 ml)
1.19
0.61–2.32
0.603
Furosemide forced diuresis (yes = 1, no = 0)
1.19
0.40–3.57
0.751
Tachycardia on POD0 (yes = 1, no = 0)
9.19
0.38–219.79
0.167
Postoperative fever (yes = 1, no = 0)
2.23
0.77–6.49
0.139
Postoperative nausea and vomiting (yes = 1, no = 0)
1.02
0.31–3.38
0.973
Additional pain medication required (yes = 1, no = 0)
0.88
0.36–2.15
0.775
Distance between the hospital and place of residence (50 km)
1.59
1.26–2.01
<0.001
Italic entries reached significance of p < 0.05 as stated in methodology
POD0 postoperative day 0
Readmission rate in the study population was 5.89% (29 readmissions). Fourteen patients after LSG (4.58%) were readmitted, while 15 after LRYGB (8.06%; p = 0.172) (Table 4). Univariate logistic regression analyses revealed statistically significant impact of operative time, intraoperative adverse events, intraoperative volume of administered fluids, oral fluid intake, postoperative intravenous fluid administration, and prolonged LOS (> 3 days vs. ≤ 3 days) on the risk of hospital readmission (Table 5). Multivariate logistic regression model revealed significant impact of occurrence of intraoperative adverse events and low oral fluid intake on the day of surgery on the risk of hospital readmission (Table 6). Intraoperative adverse events which occurred in our unit are presented in Table 7.
Table 4
Reasons for readmission
 
LSG
LRYGB
Operation site hernia
2 (0.65%)
3 (1.61%)
Cholecystitis
2 (0.65%)
3 (1.61%)
Linea alba herniation
0
2 (1.08%)
Internal hernia (Petersen space hernia)
0
1 (0.54%)
Perforated gastric ulcer
0
1 (0.54%)
GI bleeding
0
2 (1.08%)
Perianal abscess
0
1 (0.54%)
Pulmonary thrombosis
0
1 (0.54%)
Gastroesophageal reflux disease
3 (0.98%)
0
Fever of undetermined origin
1 (0.33%)
0
Chronic diarrhea
1 (0.33%)
0
Suspected ileus
1 (0.33%)
0
Dysphagia
4 (1.31%)
0
Lower abdomen pain
0
1 (0.54%)
Total
14/306 (4.58%)
15/186 (8.06%)
Table 5
Univariate logistic regression models of factors possibly affecting odds ratio of hospital readmission
Factors
OR
95% CI
P
Patient-related
Sex (M = 0, F = 1)
0.76
0.35–1.66
0.495
Age (with every 1 year)
1.02
0.99–1.06
0.208
Age (> 51 vs. ≤ 51 years)
1.14
0.47–2.77
0.765
Maximal preoperative BMI (1 kg/m2)
1.05
0.99–1.10
0.094
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2)
1.44
0.63–3.28
0.382
BMI on the day of operation (1 kg/m2)
1.03
0.97–1.09
0.404
BMI on the day of operation (> 49.74 vs. ≤ 49.74 kg/m2)
1.44
0.63–3.28
0.382
Co-morbidities
ASA class (with every point)
1.54
0.69–3.43
0.287
Cardio-vascular diseases (yes = 1, no = 0)
1.93
0.82–4.56
0.130
Arterial hypertension (yes = 1, no = 0)
1.19
0.51–2.77
0.692
Prediabetes (yes = 1, no = 0)
2.79
0.77–10.10
0.117
Diabetes mellitus (yes = 1, no = 0)
0.91
0.40–2.06
0.823
Obstructive sleep apnea (yes = 1, no = 0)
0.48
0.06–3.67
0.478
Non-alcoholic fatty liver disease (yes = 1, no = 0)
0.93
0.42–2.02
0.847
Dyslipidemia (yes = 1, no = 0)
1.65
0.73–3.74
0.227
Malnutrition (yes = 1, no = 0)
1.57
0.66–3.74
0.304
Treatment-related
Type of procedure (LRYGB vs. LSG)
1.70
0.79–3.65
0.176
Operative time (with every 1 min)
1.01
1.00–1.01
0.068
Operative time (> 150 vs. ≤ 150 min)
2.31
1.02–5.24
0.044
Intraoperative adverse effects (yes = 1, no = 0)
5.32
1.62–17.45
0.006
Intraoperative fluid volume administered (500 ml)
1.78
1.27–2.50
0.001
Postoperative period
Oral fluid intake on POD0 (100 ml)
0.86
0.74–0.99
0.030
Oral fluid intake on POD1 (100 ml)
0.94
0.88–1.01
0.072
Oral fluid intake on POD2 (100 ml)
0.91
0.84–0.98
0.010
Oral fluid intake on POD3 (100 ml)
0.92
0.81–1.04
0.162
Diuresis on POD0 (1000 ml)
1.56
0.99–2.47
0.056
Diuresis on POD1 (1000 ml)
0.74
0.40–1.36
0.337
Diuresis on POD2 (1000 ml)
0.98
0.52–1.87
0.957
Diuresis on POD3 (1000 ml)
2.01
0.93–4.34
0.072
Furosemide-forced diuresis (yes = 1, no = 0)
0.78
0.33–1.87
0.577
Intravenous fluid intake on POD0 (yes = 1, no = 0)
0.88
0.35–2.21
0.781
Intravenous fluid volume on POD0 (500 ml)
0.05
0.004–0.68
0.023
Intravenous fluid intake on POD1 (yes = 1, no = 0)
1.54
0.59–4.03
0.379
Intravenous fluid volume on POD1 (500 ml)
1.19
0.96–1.47
0.113
Intravenous fluid intake on POD2 (yes = 1, no = 0)
2.31
0.89–5.96
0.083
 
Intravenous fluid volume on POD2 (500 ml)
0.95
0.63–1.42
0.791
Heart rate on POD0 (with every 1/min)
1.01
0.96–1.05
0.767
Tachycardia on POD0 (yes = 1, no = 0)
5.14
0.55–48.33
0.151
Heart rate on POD1 (with every 1/min)
1.00
0.96–1.05
0.832
Tachycardia on POD1 (yes = 1, no = 0)
1.67
0.21–13.57
0.628
Heart rate on POD2 (with every 1/min)
1.01
0.97–1.05
0.709
Tachycardia on POD2 (yes = 1, no = 0)
0.02
0.008–62.24
0.701
Heart rate on POD3 (with every 1/min)
1.01
0.95–1.07
0.776
Tachycardia on POD3 (yes = 1, no = 0)
6.94
0.57–84.03
0.126
CPK (> 1000 vs. < 1000 U/L)
2.19
0.85–5.67
0.105
Postoperative fever (yes = 1, no = 0)
1.15
0.38–3.52
0.804
Postoperative nausea and vomiting (yes = 1, no = 0)
1.59
0.35–7.19
0.547
Additional pain medication required (yes = 1, no = 0)
1.71
0.72–4.04
0.221
Distance between the hospital and place of residence (50 km)
0.91
0.73–1.13
0.389
Prolonged LOS (> 3 vs. ≤ 3 days)
2.57
1.19–5.56
0.016
Italic entries reached significance of p < 0.05 as stated in methodology
ASA class American Society of Anesthesiologists physical status classification system, POD0 postoperative day 0, POD1 postoperative day 1, POD2 postoperative day 2, POD3 postoperative day 3, POD4 postoperative day 4, LOS length of stay, CPK creatine phosphokinase, LOS length of hospital stay
Table 6
Multivariate logistic regression model for hospital readmission
 
OR
95% CI
P
Operative time (> 150 vs. ≤ 150 min)
2.79
0.34–22.94
0.335
Intraoperative adverse effects (yes = 1, no = 0)
4.20
1.17–151.14
0.039
Intraoperative fluid volume administered (500 ml)
1.88
0.72–4.92
0.192
Oral fluid intake on POD0 (100 ml)
0.54
0.29–0.99
0.043
Intravenous fluid volume on POD0 (500 ml)
0.03
0.001–1.18
0.059
Prolonged LOS (> 3 vs. ≤ 3 days)
0.31
0.03–3.42
0.332
Italic entries reached significance of p < 0.05 as stated in methodology
POD0 postoperative day 0, POD3 postoperative day 3, LOS length of stay
Table 7
Intraoperative adverse events
 
All
Readmitted
Non-readmitted
P
Total
18/492 (3.66%)
4/29 (13.79%)
14/463 (3%)
0.015
Need for small intestine resection
6
2
4
0.041
Intraoperatively diagnosed staple line leakage
2
2
0
Inappropriate stapling that required modification of technique
2
0
2
Small intestine perforation
2
0
2
Excessive intraoperative bleeding
2
0
2
Intraoperatively diagnosed stricture
1
0
1
Intestinal serosa rupture
1
0
1
Probe immobilized with stapler
1
0
1
Intubation failure, cancelation of procedure
1
0
1
Italic entries reached significance of p < 0.05 as stated in methodology

Discussion

We report outcomes of a study, where we sought to identify risk factors for prolonged length of hospital stay, despite instituted treatment according to modern model of perioperative care (ERAS). In our unit, our aim is to discharge the patient not as early as it is possible but as soon as patients reach full functional recovery. We demonstrated that with every 100 ml of oral fluid intake on the POD0, the risk for prolonged LOS decreased by 23%. As for i.v. fluids on POD0, the need for every 500 ml increased the risk for prolonged hospital stay 1.71 times. With every 50 km distance from the hospital to place of residence, the odds for prolonged LOS increased 1.59 times. We revealed that occurrence of intraoperative adverse events (after excluding patients with perioperative complications in study design) increased 4.2 times odds ratio for readmission. Additional data on which intraoperative events led to readmission are presented in Table 7. It should be emphasized that even though the result is statistically insignificant for particular types of events, the fact the readmissions occurred only after “Need for small intestine resection” or “Intraoperatively diagnosed staple line leakage” should alert the surgeon about possible readmission. High oral fluid intake on POD0 was protective factor decreasing risk for readmission 0.54 times.
Length of stay varies among bariatric centers due to differences in perioperative pathways and discharge criteria. Recent study on predictors for LOS, which included 9593 LRYGB, reported median length of stay of 2 days (range 0–544), in which 26% of patients required > 3 days of hospitalization [17]. In a study by Dallal et al., the hospital discharged 48% of bariatric patients by postoperative day (POD) 1, 85% by POD 2, and 96% by POD 3 [18]. Other studies on this matter usually reported LOS > 3 days as prolonged LOS, which is the same threshold as we had [1921]. Different treatment protocols are administered nowadays for bariatric patients. Many researchers reported bariatric procedures performed in the fast-track surgery way; however, this requires additional actions to prepare and carry on treatment within 24-h hospital stay [2224]. In our case, patients were admitted to the hospital in the afternoon prior to the operation day. Hospital stay was planned for 3 days and patients were obligated to follow criteria for discharge upon decision making. In summary, comparison between different bariatric centers could be troublesome, not only because of qualitative differences but also due to the applied approach to the treatment protocol.
The overall readmission rate in a study by Lois et al., which included 95,294 patients after bariatric surgery, was 5.7% [19]. Recent study by Sippey et al. reported an overall 30-day readmission rate after LSG or LRYGB of 5.1% [25]. Other authors reported readmission rates after those two procedures in the range of 1.87–14.16% [18, 2633]. Despite many authors reporting more common readmissions after LRYGB compared with LSG [25, 27, 28, 34], one study documented higher rates after LSG [19]. In our study, overall readmission rate was 5.89%.
According to other studies, patient-related factors associated with prolonged LOS were age, higher preoperative BMI, male sex, number of preoperative comorbidities, and operative time [18, 3538]. Regarding demographic factors in our study, they were not significantly related to the risk of prolonged LOS. Considering comorbidities, Carter et al. in a large study involving 500 hospitals in the National Surgical Quality Improvement Program (NSQIP) database showed that after gastric by-pass, longer hospitalization was predicted by diabetes, chronic obstructive pulmonary disease, hemorrhagic diathesis, chronic kidney disease, hypoalbuminemia, but with no other patient-related factors [17]. Sun et al. showed that patients with history of congestive heart failure, peripheral vascular, and kidney diseases were more prone to have longer LOS [39]. However, in our study, neither higher ASA class nor the presence of other comorbidities was related to the risk of prolonged LOS. We proved that in the end, LRYGB was not significantly related to prolonging LOS in comparison with LSG. Similar conclusions were found Weiner et al. [40]. We failed to determine what caused the lack of influence of patient’s health status or comorbidities on our endpoints. We hypothesize that it may be caused by individualized perioperative care, which was proven in another surgical disciplines [7, 4143]. In studies by Reames et al., Carter et al., and Dallall et al., researchers concluded that the longer was the operative time, the greater was the risk for prolonged length of stay [17, 18, 20]. The same relationship was found in our study; however, a multivariate analysis revealed that it was contributing less to the risk of prolonged LOS. Nossaman et al. concluded that the volume of intravenous fluids administered during laparoscopic bariatric surgery significantly correlates to LOS and delays wound healing [37]. They showed that lower volumes of intraoperative fluid were significantly associated with longer LOS [37]. Contrary to that, we observed that patients who required larger amounts of intraoperative i.v. fluids were more prone to longer hospital stay; however, this correlation was not shown in the multivariate analysis. In our study, decreased amount of postoperative oral fluid intake (on POD0), need for i.v. fluids (POD0), and increasing distance between the hospital and place of residence were significantly contributing to increased risk of prolonged hospital stay.
In numerous papers, we found significant correlations of some patient-dependent factors and comorbidities on readmission rates, i.e., higher BMI and ASA class, diabetes mellitus, cardio-vascular, respiratory, renal co-morbidities, and chronic steroid intake, protein malnutrition were showed to be associated with increased risk of readmission [21, 25, 34, 35, 38, 39]. Treating patients in accordance to ERAS protocol probably contributed to non-significant relationship of preoperative ASA class and comorbidities with the risk of postoperative readmissions in our study [6, 7, 15, 16, 44]. We, as other researchers did, determined that BMI was not found to be a predictor of readmission [34, 45, 46].
In study by Sippey et al., the readmissions were higher after LRYGB compared with LSG [25]. In another, patients who underwent LRYGB had 60% higher risk for readmission in the 30-day postoperative time period compared to those who underwent LSG [34]. Contrary to this, we and Doumouras et al. did not observe similar relationship [26]. Operative time and intraoperative adverse events were also proved to increase risk of readmission [34, 47]. Postoperative complications were found to be associated with significant increase in readmissions in study by Khorgami et al. and other researchers [26, 34, 4850]. In our study, multivariate analysis elicited independent influence of intraoperative adverse events and oral fluid intake on POD0 as factors associated with the risk of readmission. Regarding the fact that one of the most common reason for readmission after bariatric surgery is nausea/vomiting (12.95% in study by Aman et al. [28]), the decreased amount of oral fluid intake is a reasonable risk factor for readmission. We came to similar conclusions basing on our material.
Lois et al., Dallal et al., and Baker et al. concluded that in case of patients with LOS > 3 days, the risk of readmission was several times more greater than in on day hospitalizations [18, 19, 33]. Longer LOS was also a predictor of readmission in the study by Sun et al. [39]. In our study, patients with prolonged LOS (> 3 days) were 2.57 times more likely to be readmitted in comparison with patients whose LOS was ≤ 3 days; however, the result was only significant in the univariate analysis. Generally, it has to be emphasized that the factors we found to be increasing the risk of readmission are associated with first 24–48 after since the beginning of surgery. Early discharge is a result of how patients manages the treatment during the early hours. This way we are able to select patients who are at potentially greater risk of readmission.

Limitation of the Study

The study did not focus on the potential differences arising from the severity of diabetes. Further study on the relationship between the severity of diabetes in bariatric patients and its impact on LOS and postoperative course is needed.

Conclusion

Decreased oral fluid intake, need for increased i.v. fluid administration on the day of surgery, and longer distance from habitual residence to bariatric center are potential risk factors for prolonged hospital stay. Intraoperative adverse events increase risk for hospital readmission. Greater oral fluid intake on the day of procedure was associated with lower risk for readmission.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Jagiellonian University.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Nguyen NT et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216(2):252–7.CrossRefPubMed Nguyen NT et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216(2):252–7.CrossRefPubMed
2.
Zurück zum Zitat Matłok, M., et al., Reduction of the risk of rhabdomyolysis after bariatric surgery with lower fluid administration in the perioperative period: a cohort study. Pol Arch Med Wewn, 2016. Matłok, M., et al., Reduction of the risk of rhabdomyolysis after bariatric surgery with lower fluid administration in the perioperative period: a cohort study. Pol Arch Med Wewn, 2016.
3.
Zurück zum Zitat Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.CrossRefPubMed Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.CrossRefPubMed
5.
Zurück zum Zitat Lazzati A et al. Bariatric surgery trends in France: 2005-2011. Surg Obes Relat Dis. 2014;10(2):328–34.CrossRefPubMed Lazzati A et al. Bariatric surgery trends in France: 2005-2011. Surg Obes Relat Dis. 2014;10(2):328–34.CrossRefPubMed
6.
Zurück zum Zitat Thorell A et al. Guidelines for perioperative Care in Bariatric Surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40(9):2065–83.CrossRefPubMed Thorell A et al. Guidelines for perioperative Care in Bariatric Surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40(9):2065–83.CrossRefPubMed
7.
Zurück zum Zitat Małczak, P., et al., Enhanced recovery after bariatric surgery: systematic review and meta-analysis. Obes Surg, 2016. Małczak, P., et al., Enhanced recovery after bariatric surgery: systematic review and meta-analysis. Obes Surg, 2016.
8.
Zurück zum Zitat Kaboli PJ et al. Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 veterans affairs hospitals. Ann Intern Med. 2012;157(12):837–45.CrossRefPubMed Kaboli PJ et al. Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 veterans affairs hospitals. Ann Intern Med. 2012;157(12):837–45.CrossRefPubMed
9.
Zurück zum Zitat Carey K, Lin MY. Hospital length of stay and readmission: an early investigation. Med Care Res Rev. 2014;71(1):99–111.CrossRefPubMed Carey K, Lin MY. Hospital length of stay and readmission: an early investigation. Med Care Res Rev. 2014;71(1):99–111.CrossRefPubMed
10.
Zurück zum Zitat Carey K. Measuring the hospital length of stay/readmission cost trade-off under a bundled payment mechanism. Health Econ. 2015;24(7):790–802.CrossRefPubMed Carey K. Measuring the hospital length of stay/readmission cost trade-off under a bundled payment mechanism. Health Econ. 2015;24(7):790–802.CrossRefPubMed
12.
Zurück zum Zitat Fried M et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24(1):42–55.CrossRefPubMed Fried M et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24(1):42–55.CrossRefPubMed
13.
Zurück zum Zitat von Elm E et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef von Elm E et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef
15.
Zurück zum Zitat Matłok M et al. One hundred seventy-nine consecutive bariatric operations after introduction of protocol inspired by the principles of enhanced recovery after surgery (ERAS®) in bariatric surgery. Med Sci Monit. 2015;21:791–7.CrossRefPubMedPubMedCentral Matłok M et al. One hundred seventy-nine consecutive bariatric operations after introduction of protocol inspired by the principles of enhanced recovery after surgery (ERAS®) in bariatric surgery. Med Sci Monit. 2015;21:791–7.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sinha, A., et al., Enhanced recovery after bariatric surgery in the severely obese, morbidly obese, super-morbidly obese and super-super morbidly obese using evidence-based clinical pathways: a comparative study. Obes Surg, 2016. Sinha, A., et al., Enhanced recovery after bariatric surgery in the severely obese, morbidly obese, super-morbidly obese and super-super morbidly obese using evidence-based clinical pathways: a comparative study. Obes Surg, 2016.
17.
Zurück zum Zitat Carter J et al. Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the National Surgical Quality Improvement Program. Surg Obes Relat Dis. 2015;11(2):288–94.CrossRefPubMed Carter J et al. Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the National Surgical Quality Improvement Program. Surg Obes Relat Dis. 2015;11(2):288–94.CrossRefPubMed
18.
Zurück zum Zitat Dallal RM, Trang A. Analysis of perioperative outcomes, length of hospital stay, and readmission rate after gastric bypass. Surg Endosc. 2012;26(3):754–8.CrossRefPubMed Dallal RM, Trang A. Analysis of perioperative outcomes, length of hospital stay, and readmission rate after gastric bypass. Surg Endosc. 2012;26(3):754–8.CrossRefPubMed
19.
Zurück zum Zitat Lois AW et al. The relationship between duration of stay and readmissions in patients undergoing bariatric surgery. Surgery. 2015;158(2):501–7.CrossRefPubMedPubMedCentral Lois AW et al. The relationship between duration of stay and readmissions in patients undergoing bariatric surgery. Surgery. 2015;158(2):501–7.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Reames BN et al. Influence of median surgeon operative duration on adverse outcomes in bariatric surgery. Surg Obes Relat Dis. 2015;11(1):207–13.CrossRefPubMed Reames BN et al. Influence of median surgeon operative duration on adverse outcomes in bariatric surgery. Surg Obes Relat Dis. 2015;11(1):207–13.CrossRefPubMed
21.
Zurück zum Zitat Reyes-Pérez A et al. Analysis of causes and risk factors for hospital readmission after Roux-en-Y gastric bypass. Obes Surg. 2016;26(2):257–60.CrossRefPubMed Reyes-Pérez A et al. Analysis of causes and risk factors for hospital readmission after Roux-en-Y gastric bypass. Obes Surg. 2016;26(2):257–60.CrossRefPubMed
22.
Zurück zum Zitat Bergland A, Gislason H, Raeder J. Fast-track surgery for bariatric laparoscopic gastric bypass with focus on anaesthesia and peri-operative care. Experience with 500 cases. Acta Anaesthesiol Scand. 2008;52(10):1394–9.CrossRefPubMed Bergland A, Gislason H, Raeder J. Fast-track surgery for bariatric laparoscopic gastric bypass with focus on anaesthesia and peri-operative care. Experience with 500 cases. Acta Anaesthesiol Scand. 2008;52(10):1394–9.CrossRefPubMed
23.
Zurück zum Zitat Geubbels N et al. Fast track care for gastric bypass patients decreases length of stay without increasing complications in an unselected patient cohort. Obes Surg. 2014;24(3):390–6.CrossRefPubMed Geubbels N et al. Fast track care for gastric bypass patients decreases length of stay without increasing complications in an unselected patient cohort. Obes Surg. 2014;24(3):390–6.CrossRefPubMed
24.
Zurück zum Zitat Elliott JA et al. Fast-track laparoscopic bariatric surgery: a systematic review. Updat Surg. 2013;65(2):85–94.CrossRef Elliott JA et al. Fast-track laparoscopic bariatric surgery: a systematic review. Updat Surg. 2013;65(2):85–94.CrossRef
25.
Zurück zum Zitat Sippey M et al. 30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):991–6.CrossRefPubMed Sippey M et al. 30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):991–6.CrossRefPubMed
26.
Zurück zum Zitat Doumouras AG, Saleh F, Hong D. 30-Day readmission after bariatric surgery in a publicly funded regionalized center of excellence system. Surg Endosc. 2016;30(5):2066–72.CrossRefPubMed Doumouras AG, Saleh F, Hong D. 30-Day readmission after bariatric surgery in a publicly funded regionalized center of excellence system. Surg Endosc. 2016;30(5):2066–72.CrossRefPubMed
27.
Zurück zum Zitat Chen SY et al. Assessment of postdischarge complications after bariatric surgery: a National Surgical Quality Improvement Program analysis. Surgery. 2015;158(3):777–86.CrossRefPubMed Chen SY et al. Assessment of postdischarge complications after bariatric surgery: a National Surgical Quality Improvement Program analysis. Surgery. 2015;158(3):777–86.CrossRefPubMed
28.
Zurück zum Zitat Aman MW et al. Early hospital readmission after bariatric surgery. Surg Endosc. 2016;30(6):2231–8.CrossRefPubMed Aman MW et al. Early hospital readmission after bariatric surgery. Surg Endosc. 2016;30(6):2231–8.CrossRefPubMed
29.
Zurück zum Zitat Abraham CR et al. Predictors of hospital readmission after bariatric surgery. J Am Coll Surg. 2015;221(1):220–7.CrossRefPubMed Abraham CR et al. Predictors of hospital readmission after bariatric surgery. J Am Coll Surg. 2015;221(1):220–7.CrossRefPubMed
30.
Zurück zum Zitat Kellogg TA et al. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(4):416–23.CrossRefPubMed Kellogg TA et al. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(4):416–23.CrossRefPubMed
31.
Zurück zum Zitat Weller WE, Rosati C, Hannan EL. Relationship between surgeon and hospital volume and readmission after bariatric operation. J Am Coll Surg. 2007;204(3):383–91.CrossRefPubMed Weller WE, Rosati C, Hannan EL. Relationship between surgeon and hospital volume and readmission after bariatric operation. J Am Coll Surg. 2007;204(3):383–91.CrossRefPubMed
32.
Zurück zum Zitat Saunders JK et al. 30-day readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg. 2007;17(9):1171–7.CrossRefPubMed Saunders JK et al. 30-day readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg. 2007;17(9):1171–7.CrossRefPubMed
33.
Zurück zum Zitat Baker MT et al. Length of stay and impact on readmission rates after laparoscopic gastric bypass. Surg Obes Relat Dis. 2006;2(4):435–9.CrossRefPubMed Baker MT et al. Length of stay and impact on readmission rates after laparoscopic gastric bypass. Surg Obes Relat Dis. 2006;2(4):435–9.CrossRefPubMed
34.
Zurück zum Zitat Khorgami Z et al. Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database. Surg Endosc. 2016;30(6):2342–50.CrossRefPubMed Khorgami Z et al. Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database. Surg Endosc. 2016;30(6):2342–50.CrossRefPubMed
35.
Zurück zum Zitat Jensen-Otsu E et al. The effect of Medicaid status on weight loss, hospital length of stay, and 30-day readmission after laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2015;25(2):295–301.CrossRefPubMed Jensen-Otsu E et al. The effect of Medicaid status on weight loss, hospital length of stay, and 30-day readmission after laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2015;25(2):295–301.CrossRefPubMed
36.
Zurück zum Zitat Kelles SM, Barreto SM, Guerra HL. Mortality and hospital stay after bariatric surgery in 2,167 patients: influence of the surgeon expertise. Obes Surg. 2009;19(9):1228–35.CrossRefPubMed Kelles SM, Barreto SM, Guerra HL. Mortality and hospital stay after bariatric surgery in 2,167 patients: influence of the surgeon expertise. Obes Surg. 2009;19(9):1228–35.CrossRefPubMed
37.
Zurück zum Zitat Nossaman VE et al. Role of intraoperative fluids on hospital length of stay in laparoscopic bariatric surgery: a retrospective study in 224 consecutive patients. Surg Endosc. 2015;29(10):2960–9.CrossRefPubMed Nossaman VE et al. Role of intraoperative fluids on hospital length of stay in laparoscopic bariatric surgery: a retrospective study in 224 consecutive patients. Surg Endosc. 2015;29(10):2960–9.CrossRefPubMed
38.
Zurück zum Zitat Garg T et al. Characterizing readmissions after bariatric surgery. J Gastrointest Surg. 2016;20(11):1797–801.CrossRefPubMed Garg T et al. Characterizing readmissions after bariatric surgery. J Gastrointest Surg. 2016;20(11):1797–801.CrossRefPubMed
39.
Zurück zum Zitat Sun SX, Hollenbeak CS, Rogers AM. Readmissions following gastric bypass surgery. Obes Surg. 2016;26(2):269–75.CrossRefPubMed Sun SX, Hollenbeak CS, Rogers AM. Readmissions following gastric bypass surgery. Obes Surg. 2016;26(2):269–75.CrossRefPubMed
40.
Zurück zum Zitat Weiner RA et al. Early post-operative complications: incidence, management, and impact on length of hospital stay. A retrospective comparison between laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23(12):2004–12.CrossRefPubMed Weiner RA et al. Early post-operative complications: incidence, management, and impact on length of hospital stay. A retrospective comparison between laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23(12):2004–12.CrossRefPubMed
41.
Zurück zum Zitat Pędziwiatr M et al. ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes? Med Oncol. 2016;33(6):56.CrossRefPubMedPubMedCentral Pędziwiatr M et al. ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes? Med Oncol. 2016;33(6):56.CrossRefPubMedPubMedCentral
42.
43.
Zurück zum Zitat Pędziwiatr M et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol. 2016;42(6):779–87.CrossRefPubMed Pędziwiatr M et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol. 2016;42(6):779–87.CrossRefPubMed
44.
Zurück zum Zitat Feldheiser A et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60(3):289–334.CrossRefPubMed Feldheiser A et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60(3):289–334.CrossRefPubMed
46.
Zurück zum Zitat Telem DA et al. Hospital admissions greater than 30 days following bariatric surgery: patient and procedure matter. Surg Endosc. 2015;29(6):1310–5.CrossRefPubMed Telem DA et al. Hospital admissions greater than 30 days following bariatric surgery: patient and procedure matter. Surg Endosc. 2015;29(6):1310–5.CrossRefPubMed
47.
Zurück zum Zitat Tayne S et al. Risk factors for 30-day readmissions and modifying postoperative care after gastric bypass surgery. J Am Coll Surg. 2014;219(3):489–95.CrossRefPubMed Tayne S et al. Risk factors for 30-day readmissions and modifying postoperative care after gastric bypass surgery. J Am Coll Surg. 2014;219(3):489–95.CrossRefPubMed
49.
Zurück zum Zitat Lawson EH et al. Association between occurrence of a postoperative complication and readmission: implications for quality improvement and cost savings. Ann Surg. 2013;258(1):10–8.CrossRefPubMed Lawson EH et al. Association between occurrence of a postoperative complication and readmission: implications for quality improvement and cost savings. Ann Surg. 2013;258(1):10–8.CrossRefPubMed
50.
Zurück zum Zitat Lawson EH et al. Identification of modifiable factors for reducing readmission after colectomy: a national analysis. Surgery. 2014;155(5):754–66.CrossRefPubMed Lawson EH et al. Identification of modifiable factors for reducing readmission after colectomy: a national analysis. Surgery. 2014;155(5):754–66.CrossRefPubMed
Metadaten
Titel
Risk Factors for Prolonged Length of Hospital Stay and Readmissions After Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass
verfasst von
Piotr Major
Michał Wysocki
Grzegorz Torbicz
Natalia Gajewska
Alicja Dudek
Piotr Małczak
Michał Pędziwiatr
Magdalena Pisarska
Dorota Radkowiak
Andrzej Budzyński
Publikationsdatum
31.07.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2844-x

Weitere Artikel der Ausgabe 2/2018

Obesity Surgery 2/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.